Download a summary of the ORION study. Real-world safety and effectiveness of Toujeo® in patients with Type 2 Diabetes who choose to fast during Ramadan.
- Updated set of criteria for risk stratification
- Information on the impact of fasting on physical and mental well-being
- Specific guidance on the management of T1 & T2 in special populations
- Information on changes to the risk of comorbidities
Read the full publication of the ORION observational study in patients with Type 2 Diabetes who choose to fast during Ramadan.
1. Diabetes and Ramadan Practical Guidelines 2021. Available at: https://www.idf.org/our-activities/education/diabetes-and-ramadan/healthcare-professionals.html [Accessed: February 2021].